Amedisys Reports Second Quarter Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Amedisys Reports Second Quarter Financial Results

Mizuho Securities Downgrades Amedisys (AMED) Neutral, PT Cut to $55

August 3, 2016 7:06 AM EDT

Mizuho Securities downgraded Amedisys (NASDAQ: AMED) from Buy to Neutral and cut the price target to $55.00 (from $57.00), following the company's 2Q earnings report. Management pointed out that it had underestimated the HCHB disruption costs previously and is working to correct that. As a... More